MONTELUKAST EG 5 mg, chewable tablet 28 tablets
Active ingredients: Montelukast, Montelukast sodium
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Chewable tablet28 tabletsorale
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- MONTELUKAST EG 5 mg, comprimé à croquer
- Pharmaceutical form
- comprimé à croquer
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) polyamide aluminium PVC-Aluminium de 28 comprimé(s) avec indication des jours de la semaine
- Marketing authorisation holder
- EG LABO - LABORATOIRES EUROGENERICS
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 26 Feb 2013
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65451809CIP74999182CIP133400949991822Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MONTÉLUKASTcomprimé | 5 mg · un comprimé | FT |
| MONTÉLUKAST SODIQUEcomprimé | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.